Zhejiang Shengda Pharm
Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.
Zhejiang Shengda Pharm (603079) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.028x
Based on the latest financial reports, Zhejiang Shengda Pharm (603079) has a cash flow conversion efficiency ratio of 0.028x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.27 Million) by net assets (CN¥1.60 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Shengda Pharm - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Zhejiang Shengda Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Shengda Pharm Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Shengda Pharm ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Broedrene A&O Johansen A/S Series B
CO:AOJ-B
|
0.009x |
|
NICHOLS PLC LS-10
F:NRV
|
N/A |
|
Jiangsu Lanfeng Bio-chemical Co Ltd
SHE:002513
|
-0.507x |
|
Berry Petroleum Corp
NASDAQ:BRY
|
0.087x |
|
Lanzhou Minbai Shareholding Group Co Ltd
SHG:600738
|
0.018x |
|
Shandong Zhangqiu Blower Co Ltd
SHE:002598
|
-0.016x |
|
Waffer Technology Corp
TW:6235
|
0.118x |
|
Hailir Pesticides and Chemicals Group Co Ltd
SHG:603639
|
0.048x |
Annual Cash Flow Conversion Efficiency for Zhejiang Shengda Pharm (2012–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Shengda Pharm from 2012 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.28 Billion | CN¥147.88 Million | 0.115x | +127.05% |
| 2023-12-31 | CN¥1.27 Billion | CN¥64.42 Million | 0.051x | +67.37% |
| 2022-12-31 | CN¥1.34 Billion | CN¥40.72 Million | 0.030x | -45.58% |
| 2021-12-31 | CN¥1.34 Billion | CN¥74.46 Million | 0.056x | -77.85% |
| 2020-12-31 | CN¥1.33 Billion | CN¥333.20 Million | 0.251x | +291.54% |
| 2019-12-31 | CN¥911.71 Million | CN¥58.55 Million | 0.064x | -40.01% |
| 2018-12-31 | CN¥828.42 Million | CN¥88.69 Million | 0.107x | -13.68% |
| 2017-12-31 | CN¥768.71 Million | CN¥95.33 Million | 0.124x | -25.25% |
| 2016-12-31 | CN¥440.02 Million | CN¥73.00 Million | 0.166x | -50.80% |
| 2015-12-31 | CN¥439.09 Million | CN¥148.07 Million | 0.337x | +218.46% |
| 2014-12-31 | CN¥324.87 Million | CN¥34.40 Million | 0.106x | -71.73% |
| 2013-12-31 | CN¥281.09 Million | CN¥105.28 Million | 0.375x | -36.72% |
| 2012-12-31 | CN¥185.99 Million | CN¥110.08 Million | 0.592x | -- |